Codexis and Bristol-Myers Squibb extend the term of research agreement
Codexis Achieves Milestone
Codexis, Inc. announced it has extended the term of an existing research agreement with Bristol-Myers Squibb Company. Codexis also announced that it will receive an undisclosed milestone payment for having successfully achieved the program's research milestone.
The research agreement was announced May 2005 and focused on improving biocatalyst productivity for an undisclosed product candidate in the Bristol-Myers Squibb pipeline using Codexis' proprietary MolecularBreeding(TM) directed evolution platform. Under the extended term of the agreement Codexis will receive additional undisclosed research funding and an additional payment, at Bristol-Myers Squibb's option, upon delivery of an enzyme for pilot-scale testing at Bristol-Myers Squibb. Further terms were not disclosed.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Paxillus_involutus
Category:KAZAL_domain
Stealth-adapted_virus

Scientists spin artificial silk from whey protein - X-ray study throws light on key process for production
When Tooth Decay Becomes Fatal - Researchers to study role of oral streptococci in serious diseases
Category:Orthodontic_Technicians_Association
Advanced Cell Technology Announces Creation of Human Embryonic Stem Cell Lines Without the Destruction of Embryos - Breakthrough Approach Improves Efficiency to Levels Reported in the Conventional Stem Cell Derivation Techniques

Collagen controlling the thickness and juvenile state of skin
Journal_of_Bone_&_Joint_Surgery
Category:Marine_biologists
